PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0010068|coronary artery disease |
| Sentences | 38 |
| PubMedID- 25285291 | Association of metabolic syndrome with severity of coronary artery disease. |
| PubMedID- 21743260 | The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome. |
| PubMedID- 25664056 | Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome. |
| PubMedID- 21575630 | Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. |
| PubMedID- 21986591 | A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant-antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease. |
| PubMedID- 22045340 | In fact, major depression is associated with increased volumes of visceral fat and high prevalence of the metabolic syndrome, leading to coronary artery disease. |
| PubMedID- 21847126 | There is also potential for wider health benefits; colorectal cancer shares similar risk factors, such as smoking and the metabolic syndrome, with coronary artery disease; thus, aspirin could potentially be beneficial from both an oncological and cardiological perspective (chan et al, 2007). |
| PubMedID- 21498926 | Adipose tissue gene expression of adiponectin, tumor necrosis factor-alpha and leptin in metabolic syndrome patients with coronary artery disease. |
| PubMedID- 21039444 | Background: the metabolic syndrome is associated with coronary artery disease (cad) and with peripheral artery disease (pad), but the underlying mechanisms explaining these associations have not yet been completely clarified. |
| PubMedID- 23829426 | Elevating triglycerides (tg) level, an essential component of the metabolic syndrome, is independently associated with coronary artery disease (cad) [1]. |
| PubMedID- 20424363 | Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease. |
| PubMedID- 24795698 | This variant has been associated with metabolic syndrome in patients with coronary artery disease (199). |
| PubMedID- 24055729 | The aim of this study was to investigate the association between c-reactive protein (crp) gene polymorphism and metabolic syndrome (mets) with premature coronary artery disease (pcad). |
| PubMedID- 23007990 | The 11beta-hsd-1 expression was evaluated by qrt-pcr in ea and aa tissues of 20 metabolic syndrome patients with coronary artery disease (metabolic syndrome group) and 10 non-metabolic syndrome patients without coronary artery disease (controls). |
| PubMedID- 24897239 | Association of neuropeptide y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease. |
| PubMedID- 24370221 | Purpose: to compare coronary plaque burden, composition, distribution and the degree of coronary artery stenosis in invasive coronary angiography (ica) diagnosed coronary artery disease (cad) patients with or without metabolic syndrome (mets). |
| PubMedID- 21785745 | Accumulating evidence has suggested that adipokines play an important role in the development of coronary artery disease in patients with metabolic syndrome [8-13]. |
| PubMedID- 25288499 | Effect of low serum total bilirubin levels (coronary artery disease in patients with metabolic syndrome. |
| PubMedID- PMC3382722 | 14. effects of glp-1 receptor agonist on ca2+ handling of coronary smooth muscle cells from metabolic syndrome ossabaw swine with coronary artery disease. |
| PubMedID- 25935836 | Reported that epicardial fat and pericoronary fat are associated with the existence of obesity and metabolic syndrome in patients with coronary artery disease [13]. |
| PubMedID- 21576834 | Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. |
| PubMedID- 21718908 | Objectives: our purpose was to clarify the clinical utility of identifying metabolic syndrome (mets) in patients with coronary artery disease (cad). |
| PubMedID- 23734250 | Our previous studies showed that most individuals can engage in this type of exercise training as it has been performed without any adverse events in obese and overweight individuals [21], in persons with the metabolic syndrome [19], in patients with coronary artery disease [20], patients with intermittent claudication [40], or after coronary artery bypass surgery [41]. |
| PubMedID- 22813403 | Prevalence of metabolic syndrome in patients with angiographically proven coronary artery disease presenting to a tertiary care hospital in delhi, india. |
| PubMedID- 22978689 | Cystatin c and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. |
| PubMedID- 21714290 | The inclusion of a short course of metformin in complex therapy of coronary artery disease with metabolic syndrome does not alter the clinical features of disease. |
| PubMedID- 26205896 | Previously, we had reported that a-fabp was associated with metabolic syndrome in patients with coronary artery disease and in hemodialysis patients [9, 10]. |
| PubMedID- 21570644 | Association of angiotensin ii type 1 receptor gene a1166c polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease. |
| PubMedID- 20009357 | Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. |
| PubMedID- 21988056 | Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. |
| PubMedID- 21505504 | Indeed, others have reported that inflammatory and vascular biomarkers only partially explain the association of metabolic syndrome with coronary artery disease (jacobs et al., 2009). |
| PubMedID- 25729766 | To our knowledge, this is the first study to document arterial enlargement in a metabolic syndrome animal model with diffuse coronary artery disease (dcad) in the absence of severe focal stenosis. |
| PubMedID- 23706945 | Calcium-phosphorus product concentration is a risk factor of coronary artery disease in metabolic syndrome. |
| PubMedID- 24209601 | In diabetic patients, after adjusting for possible confounding factors including age, gender, bmi, risk factors for coronary artery disease, duration of diabetes, metabolic syndrome, impaired renal function, and multivessel disease, ga > 18.3% but not hba1c > 7% remained an independent determinant for low collateralization (figure 3). |
| PubMedID- 20156070 | Background: the association of metabolic syndrome with coronary artery disease (cad) has been studied extensively. |
| PubMedID- 24142676 | Is metabolic syndrome related with coronary artery disease severity and complexity: an observational study about idf and aha/nhlbi metabolic syndrome definitions. |
| PubMedID- 21134342 | Serum slox-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome. |
| PubMedID- 20424361 | Combination of serum adiponectin level and metabolic syndrome is closely associated with coronary artery disease in japanese subjects with good glycemic control. |
Page: 1